Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD

被引：5
|
作者：
Ray K.
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2021年 / 18卷 / 5期
关键词：
D O I：
10.1038/s41575-021-00445-1
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：286 / 286
相关论文
共 50 条
  • [31] SARS-CoV-2 Antibody Responses in Pediatric Patients: A Bibliometric Analysis
    Maniu, Ionela
    Maniu, George Constantin
    Antonescu, Elisabeta
    Duica, Lavinia
    Grigore, Nicolae
    Totan, Maria
    BIOMEDICINES, 2023, 11 (05)
  • [32] Antibody responses to SARS-CoV-2 in patients with COVID-19
    Quan-Xin Long
    Bai-Zhong Liu
    Hai-Jun Deng
    Gui-Cheng Wu
    Kun Deng
    Yao-Kai Chen
    Pu Liao
    Jing-Fu Qiu
    Yong Lin
    Xue-Fei Cai
    De-Qiang Wang
    Yuan Hu
    Ji-Hua Ren
    Ni Tang
    Yin-Yin Xu
    Li-Hua Yu
    Zhan Mo
    Fang Gong
    Xiao-Li Zhang
    Wen-Guang Tian
    Li Hu
    Xian-Xiang Zhang
    Jiang-Lin Xiang
    Hong-Xin Du
    Hua-Wen Liu
    Chun-Hui Lang
    Xiao-He Luo
    Shao-Bo Wu
    Xiao-Ping Cui
    Zheng Zhou
    Man-Man Zhu
    Jing Wang
    Cheng-Jun Xue
    Xiao-Feng Li
    Li Wang
    Zhi-Jie Li
    Kun Wang
    Chang-Chun Niu
    Qing-Jun Yang
    Xiao-Jun Tang
    Yong Zhang
    Xia-Mao Liu
    Jin-Jing Li
    De-Chun Zhang
    Fan Zhang
    Ping Liu
    Jun Yuan
    Qin Li
    Jie-Li Hu
    Juan Chen
    Nature Medicine, 2020, 26 : 845 - 848
  • [33] Effect of SARS-CoV-2 Vaccines in Patients with IBD?
    Numberger, Markus
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (06): : 892 - 892
  • [34] Antibody responses to SARS-CoV-2 vaccination outperform responses induced by natural infection in patients with IBD receiving immunosuppressive medications: a report from the ICARUS-IBD consortium.
    Cueto, E. Gonzalez
    Matthew, E.
    Wellens, J.
    Pazos, V. Martinez
    Thompson, C.
    Klenerman, P.
    Cadwell, K.
    Colombel, J. F.
    Satsangi, J.
    Wong, S. Y.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I228 - I230
  • [35] SARS-COV-2 in Colorectal Cancer of IBD Patients
    Watts, M. M. Bosca
    Navarro, S.
    Rosello, S.
    Varela, J. M.
    Gonzalez, S.
    Fernandez, U.
    Sanahuja, A.
    Mongort, C.
    Garcia, T.
    Suria, C.
    Tosca, J.
    Anton, R.
    Merino, V
    Ponce, M.
    Villagrasa, R.
    Pla, V
    Moro, D.
    Casado, D.
    Navarro, D.
    Pascual, I
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I757 - I756
  • [36] The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
    Higgins, Peter D. R.
    Ng, Siew
    Danese, Silvio
    Rao, Krishna
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [37] Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
    Sui, Zhiwei
    Dai, Xinhua
    Lu, Qingbin
    Zhang, Yulan
    Huang, Min
    Li, Shufen
    Peng, Tao
    Xie, Jie
    Zhang, Yongzhuo
    Wu, Chunchen
    Xia, Jianbo
    Dong, Lianhua
    Yang, Jiayi
    Huang, Wenfeng
    Liu, Siyuan
    Wang, Ziquan
    Li, Ke
    Yang, Qingfang
    Zhou, Xi
    Wu, Ying
    Liu, Wei
    Fang, Xiang
    Peng, Ke
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [38] Frequency of B-cell subsets in infliximab-treated paediatric IBD patients
    Schnell, A.
    Schwarz, B.
    Wahlbuhl-Becker, M.
    Allabauer, I.
    Rechenauer, T.
    Siebenlist, G.
    Kaspar, S.
    Ehrsam, C.
    Rueckel, A.
    Rascher, W.
    Hoerning, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S228 - S228
  • [39] Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
    Hannah Kinoshita
    Jessica Durkee-Shock
    Mariah Jensen-Wachspress
    Vaishnavi V. Kankate
    Haili Lang
    Christopher A. Lazarski
    Anjeni Keswani
    Kathleen C. Webber
    Kimberly Montgomery-Recht
    Magdalena Walkiewicz
    Luigi D. Notarangelo
    Peter D. Burbelo
    Ivan Fuss
    Jeffrey I. Cohen
    Catherine M. Bollard
    Michael D. Keller
    Journal of Clinical Immunology, 2021, 41 : 1146 - 1153
  • [40] Vitamin D concentrations are not associated with anti-SARS-CoV-2 antibody responses following mRNA COVID-19 vaccine in IBD patients treated with infliximab
    Smith, R.
    Liu, Z.
    Laskey, K.
    Lin, S.
    Chanchlani, N.
    Nice, R.
    Roberts, C.
    Alexander, J.
    McDonald, Timothy J.
    Bewshea, Claire
    Kennedy, N.
    Goodhand, J.
    Powell, N.
    Ahmad, T.
    GUT, 2023, 72 (SUPPL_2) : A114 - A115
12345